{"paper_id":"c26716eb-17e9-47b5-b138-7449c6f33924","body_text":"Main Article Content\nAbstract\nSubject – polymorphism of genes of estrogen-metabolising enzymes in patients with endometriosis.\nObjective – to perform analysis of relationship among allelic variants of genes of oestrogen-metabolising enzymes and development of external genital endometriosis (EGE), variants of its clinical progression and multiple-modality treatment efficacy.\nMethods. Laparoscopy was performed for 417 women with EGE (treatment group) and 112 women without EGE (control group). After laparoscopically verified diagnosis for 358 women from both groups (251 with EGE and 107 without EGE) there were regions of polymorphic genes of estrogen-metabolising enzymes A-4889G CYP1A1, С-734А CYP1A2, G-638А SULT1A1 and С-174T SULT1E1 identified in RFLP-analysis.\nMain results. It has been established that carriage of not only separate polymorphic genes of estrogen-metabolising enzymes CYP1A1 A-4889G (Allele G and Genotypes GG, АG) and CYP1A2 С-734А (Allele А and Genotypes СА, АА), but also their combinations predisposes to EGE development in women of reproductive age. Carriage of Genotype СA of polymorphism С-734А of CYP1A2 gene predisposes to development of pelvic pains during EGE. The most potent combination of polymorphisms of genes of estrogen-metabolising enzymes which predisposes to EGE development is CYP1A1АА/CYP1A2СА/SULT1A1GG/SULT1E1CC combination, while CYP1A1АА/CYP1A2СС/SULT1A1GА/SULT1E1CC combination predisposes to formation of I-II stages of EGE distribution, as well as CYP1A1АА/CYP1A2СА/SULT1A1GG/SULT1E1CC combination predisposes to development of endometriosis-associated infertility, while CYP1A1АG/CYP1A2CC/SULT1A1GA/SULT1E1CC combination predisposes to efficient treatment of infertility during EGE.\nScope of application. The obtained results will allow to form risk groups of EGE development with the purpose of its primary prevention and efficient treatment of endometriosis-associated infertility.\nConclusions. Polymorphic variants of estrogen-metabolising enzymes A-4889G CYP1A1, С-734А CYP1A2, G-638А SULT1A1 and С-174T SULT1E1 (separately or in combinations) predispose to EGE development, and are associated with its clinical evidence, distribution stage and treatment efficacy.Keywords\nArticle Details\nInformation about financing and conflict of interests\nThe authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.\nThis work is licensed under a Creative Commons Attribution 4.0 License.\nHow to Cite\nReferences\nBuggio L, Somigliana E, Barbara G, Frattaruolo MP, Vercellini P. Oral and depot progestin therapy for endometriosis: towards a personalized medicine. Expert Opin. Pharmacother. 2017; (24): 1-13. doi: 10.1080/14656566.2017.1381086\nYoung VJ, Ahmad SF, Duncan WC, Horne AW. The role of TGF-β in the pathophysiology of peritoneal endometriosis. Hum. Reprod. Update. 2017; 23(5): 548-559. doi: 10.1093/humupd/dmx016.\nKolgushkina TN. Prakticheskaja ginekologija. Minsk, 2004. 173 р. Russian (Колгушкина Т.Н. Практическая гинекология. Минск, 2004. 173 с.)\nIshhenko AI, Kudrina EA, Stanoevich IV, Bahvalova AA, Romadanova JuA. Modern problems of external genital endometriosis. Obstetrics and Gynecology. 2007; (5): 67-73. Russian (Ищенко А.И., Кудрина Е.А., Станоевич И.В., Бахвалова А.А., Ромаданова Ю.А. Современные проблемы наружного генитального эндометриоза //Акушерство и гинекология. 2007. № 5. С. 67-73)\nArtymuk NV, Guljaeva LF, Zotova OA, Hvostova EP. The role of polymorphisms genes of detoxification of xenobiotics in the development of endometriosis. Journal of obstetrics and womans diseases. 2012; (6): 18-24. Russian (Артымук Н.В., Гуляева Л.Ф., Зотова О.А., Хвостова Е.П. Полиморфизм генов метаболизма эстрогенов у женщин с аденомиозом //Журнал акушерства и женских болезней. 2012. № 6. С. 18-24)\nSuturina LV, Skljar NV, Labygina AV, Sholohov LF, Kovalenko II. The estrogen metabolism disorders in woman with uterine myoma and infertility. Mother and Baby in Kuzbass. 2009; 1(36): 27-30. Russian (Сутурина Л.В., Скляр Н.В., Лабыгина А.В., Шолохов Л.Ф., Коваленко И.И. Нарушения метаболизма эстрогенов у женщин с миомой матки и бесплодием //Мать и Дитя в Кузбассе. 2009. № 1(36). С. 27-30)\nHarenkova EL, Artymuk NV, Guljaeva LF. The influence of the polymorphism of enzymes in women with endometrial hyperplasia and endometrial cancer. Bulletin of the East Siberian Scientific Center SBRAMS. 2010; 6(2): 84-87. Russian (Харенкова Е.Л., Артымук Н.В., Гуляева Л.Ф. Влияние полиморфизма генов ферментов метаболизма эстрогенов на развитие гиперпластических процессов и рака эндометрия //Бюллетень ВСНЦ СО РАМН. 2010. № 6(2). С. 84-87)\nAfanas'eva NA, Hvostova EP, Pustyl'njak VO, Chasovnikova OB, Krasil'nikov SJe, Guljaeva LF. Analysis of genetic polymorphisms in estrogen metabolizing enzymes in ovarian cancer patients in the Siberia region. Molecular medicine. 2013; (1): 16-19. Russian (Афанасьева Н.А., Хвостова Е.П., Пустыльняк В.О., Часовникова О.Б., Красильников С.Э., Гуляева Л.Ф. Анализ генетического полиморфизма ферментов метаболизма эстрогенов у больных раком яичников в Сибирском регионе //Молекулярная медицина. 2013. № 1. С. 16-19)\nPrimak AV. Metabolizm jestrogenov u zhenshhin. Obshhie predstavlenija i klinicheskaja praktika. Jesteticheskaja medicina. 2006; (2): 208-214. Russian (Примак А.В. Метаболизм эстрогенов у женщин. Общие представления и клиническая практика //Эстетическая медицина. 2006. № 2. С. 208-214)\nAdamyan LV, Kulakov VI, Andreeva EN. Endometriozy. M.: Meditsina, 2006: 416 p. Russian (Адамян Л.В., Кулаков В.И., Андреева Е.Н. Эндометриозы. М.: Медицина, 2006: 416 с.\nStefansson H, Geirsson RT, Steinthorsdottir V, Jonsson H, Manolescu A, Kong A et al. Genetic factors contribute to the risk of developing endometriosis. Hum. Reprod. 2002; 17(3): 555-559\nTempfer CB, Simoni M, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders. Hum. Reprod. 2009; (15): 97-118. doi: 10.1093/humupd/dmn024\nPrudnikov AV, Pochos EV, Mihajlova ON, Guljaeva LF, Ljahovich VV. Genetic polymorphism of estrogen metabolizing enzymes in female with hysteromyoma. Vestnik NGU. Serija: Biologija, klinicheskaja medicina. 2005; 3(1): 47-55. Russian (Прудников А.В., Почос Е.В., Михайлова О.Н., Гуляева Л.Ф., Ляхович В.В. Генетический полиморфизм ферментов метаболизма эстрогенов у больных с миомой матки //Вестник НГУ. Серия: Биология, клиническая медицина. 2005. Т. 3, Вып. 1. С. 47-55)\nLow YL, Li Y, Humphreys K, Thalamuthu A, Li Y, Darabi H et al. Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility. PLoS Genet. 2010; 6(7): E. 1001012. doi.org/10.1371/journal.pgen.1001012\nPechkovskij EV, Shadrina AS, Bojarskih UA, Selezneva IA, Sinkina TV, Lazarev AF et al. The polymorphism of genes of synthesis and metabolism of estrogens and the risk of breast cancer. Russian Clinical Laboratory Diagnostics. 2014; (2): 19-23. Russian (Печковский Е.В., Шадрина А.С., Боярских У.А., Селезнева И.А., Синкина Т.В., Лазарев А.Ф. и др. Полиморфизм генов синтеза и метаболизма эстрогенов и риск рака молочной железы //Клиническая лабораторная диагностика. 2014. № 2. С. 19-23)\nStupko EE, Shenin VA, Kolesnikova LI, Labygina AV, Suturina LV. The role of polymorphisms genes of detoxification of xenobiotics in the development of endometriosis and hysteromyoma in woman. Sibirskij Medicinskij Zurnal (Irkutsk). 2011; (5): 5-8. Russian (Ступко Е.Е., Шенин В.А., Колесникова Л.И., Лабыгина А.В., Сутурина Л.В. Роль полиморфизмов генов детоксикации ксенобиотиков в развитии миомы матки и эндометриоза //Сибирский медицинский журнал. 2011. № 5. С. 5-8)\nPeng DX, He YL, Qiu LW, Yang F, Lin JM. Susceptibility to endometriosis in women of Han Nationality in Guangdong Province associated with Msp I polymorphisms of cytochrome P450 1A1 gene. Di Yi Jun Yi Da Xue Xue Bao. 2002; 22(9): 814-816\nIizuka S, Kosugi Y, Isaka K, Takayama M. Could polymorphisms of N-acetyltransferase 2 (NAT2), glutathione S-transferase M1 (GSTM1), and cytochrome P450 (CYP1A1) be responsible for genetic predisposition to endometriosis among Japanese? J. Tokyo Med. Univ. 2003; (61): 59-66\nBabu KA, Reddy NG, Deendayal M, Kennedy S, Shivaji S. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and their relationship with advanced stages of endometriosis in South Indian women. Pharmacogenet. Genomics. 2005; 15(3): 167-172\nHuber A, Keck CC, Hefler LA, Schneeberger C, Huber JC, Bentz EK et al. Ten estrogen-related polymorphisms and endometriosis: a study of multiple gene-gene interactions. Obstet. Gynecol. 2005; 106(5): 1025-1031. doi:10.1097/01.AOG.0000185259.01648.41\nJuo SH, Wang TN, Lee JN, Wu MT, Long CY, Tsai EM. CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women. Hum. Reprod. 2006; 21(6): 1498-1502. doi:10.1093/humrep/del033\nSmuc T, Pucelj MR, Sinkovec J, Husen B, Thole H, Lanisnik Rizner T. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol. Endocrinol. 2007; 23(2): 105-111. doi:10.1080/09513590601152219\nSmuc T, Hevir N, Ribic-Pucelj M, Husen B, Thole H, Rizner TL. Disturbed estrogen and progesterone action in ovarian. Mol. Cell Endocrinol. 2009; 301(1-2): 59-64. doi: 10.1016/j.mce.2008.07.020\nColette S, Defrère S, Van Kerk O, Van Langendonckt A, Dolmans MM, Donnez J. Differential expression of steroidogenic enzymes according to endometriosis type. Fertil. Steril. 2013; 100(6): 1642-1649. doi: 10.1016/j.fertnstert.2013.08.003\nBurney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology. 2007; 148(8): 3814-3826. doi:10.1210/en.2006-1692\nRižner TL. The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases. Front. Pharmacol. 2016; 18(7): 30. doi: 10.3389/fphar.2016.00030\nDassen H, Punyadeera C, Kamps R, Delvoux B, Van Langendonckt A, Donnez J et al. Estrogen metabolizing enzymes in endometrium and endometriosis. Hum. Reprod. 2007; 22(12): 3148-3158. doi:10.1093/humrep/dem310\nSeli E, Arici A. Endometriosis: interaction of immune and endocrine systems. Semin. Reprod. Med. 2003; 21(2): 135-144. doi:10.1055/s-2003-41320\nAndreeva EN, Gavrilova EF. Endometriosis: ways of the decision of a problem to the XXI century. Bulletin of Reproductive Health. 2011; 2: 3-10. Russian (Андреева Е.Н., Гаврилова Е.Ф. Генитальный эндометриоз: пути решения проблемы в XXI веке //Вестник репродуктивного здоровья. 2011. № 2. С. 3-10)\nMarzhevskaya AM, Rishchuk SV, Gusev SN, Tatarova NA, Mirsky VE, Norekyan SI. Correction of Reproductive disorders in patients with endometriosis(areview). Preventive and clinical medicine. 2014; 4(53): 59-71. Russian (Маржевская А.М., Рищук С.В., Гусев С.Н., Татарова Н.А., Мирский В.Е., Норекян С.И. Репродуктивные нарушения у больных эндометриозом и их коррекция //Профилактическая и клиническая медицина. 2014. № 4(53). С. 59-71)\nCheng YH, Imir A, Fenkci V, Yilmaz MB, Bulun SE. Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism. Am. J. Obstet. Gynecol. 2007; 196(4): 391-398. doi:10.1016/j.ajog.2006.12.014\nIto K, Utsunomiya H, Suzuki T, Saitou S, Akahira J, Okamura K et al. 17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders. Mol. Cell. Endocrinol. 2006; 248(1-2): 136-140. doi:10.1016/j.mce.2005.11.038","source_license":"CC0","license_restricted":false}